Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbvie, Advisor, alphabetical, AML, asinter, AVEO, begun, bladder, Blue, Carbogen, Citigroup, customer, CytomX, declared, depict, Ellie, Euro, frame, fulfill, Harrison, IDEXX, IGN, Island, johnston, KAITLIN, KRISTINE, lesser, masking, Michigan, monotherapy, myeloid, notable, Oxford, partway, PDC, Pharmacology, PhD, PHS, presence, probody, reciprocal, relapsed, relinquished, Rhode, Shield, shortly, sublicensed, surface, tubulin, urinary, week, weekly, whichever
Removed:
Abgenix, acquired, Acting, advancing, Alnylam, ANDA, bioavailability, biochemical, broader, carcinoid, certification, chemical, clinic, complicated, Dentistry, device, differentiated, Elixir, EMILIA, hematological, humanization, humanizing, immune, immunoconjugate, Institute, invalidity, ion, landlord, larger, literature, lorvotuzumab, lymphoblastic, MCC, Merkel, mertansine, MM, moiety, murine, neuroendocrine, nonperformance, origin, pertuzumab, prohibit, resistance, Rochester, SCLC, sponsored, TAP, Theresa, toxicology, unrealized, Wingrove
Filing tables
Filing exhibits
Related press release
IMGN similar filings
Filing view
External links